Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Structure of the C2 domain of human factor VIII at 1.5 Å resolution

Abstract

Human factor VIII is a plasma glycoprotein that has a critical role in blood coagulation1,2. Factor VIII circulates as a complex with von Willebrand factor3. After cleavage by thrombin, factor VIIIa associates with factor IXa at the surface of activated platelets or endothelial cells4,5. This complex activates factor X (refs 6, 7), which in turn converts prothrombin to thrombin in the presence of factor Va (refs 8, 9). The carboxyl-terminal C2 domain of factor VIII contains sites that are essential for its binding to von Willebrand factor and to negatively charged phospholipid surfaces4,10,11. Here we report the structure of human factor VIII C2 domain at 1.5 Å resolution. The structure reveals a β-sandwich core, from which two β-turns and a loop display a group of solvent-exposed hydrophobic residues. Behind the hydrophobic surface lies a ring of positively charged residues. This motif suggests a mechanism for membrane binding involving both hydrophobic and electrostatic interactions. The structure explains, in part, mutations in the C2 region of factor VIII that lead to bleeding disorders in haemophilia A.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Ribbon diagram and proposed membrane-binding mode.
Figure 2: Molecular surface of the factor VIII C2 domain.
Figure 3: Location of haemophilia-A-associated point mutations in the factor VIII C2 domain.

Similar content being viewed by others

References

  1. Kane,W. H. & Davie,E. W. Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 71, 539–555 (1988).

    CAS  PubMed  Google Scholar 

  2. Kaufman,R. J. Biological regulation of factor VIII activity. Annu. Rev. Med. 43, 325–339 (1992).

    Article  CAS  Google Scholar 

  3. Fay,P. J., Coumans,J.-V. & Walker,F. J. Von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J. Biol. Chem. 266, 2172–2177 (1991).

    CAS  PubMed  Google Scholar 

  4. Foster,P. A., Fulcher,C. A., Houghten,R. A. & Zimmerman,T. S. Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine. Blood 75, 1999–2004 (1990).

    CAS  PubMed  Google Scholar 

  5. Duffy,E. J., Parker,E. T., Mutucumarana,V. P., Johnson,A. E. & Lollar,P. Binding of factor VIIIa and factor VIII to factor IXa on phospholipid vesicles. J. Biol. Chem. 267, 17006–17011 (1992).

    CAS  PubMed  Google Scholar 

  6. Duffy,E. J. & Lollar,P. Intrinsic pathway activation of factor X and its activation peptide-deficient derivative, factor Xdes-143-191. J. Biol. Chem. 267, 7821–7827 (1992).

    CAS  PubMed  Google Scholar 

  7. van Dieijen,G., Tans,G., Rosing,J. & Hemker,H. C. The role of phospholipid and factor VIIIa in the activation of bovine factor X. J. Biol. Chem. 256, 3433–3442 (1981).

    CAS  PubMed  Google Scholar 

  8. Krishnaswamy,S., Nesheim,M. E., Prydzial,E. L. G. & Mann,K. G. Assembly of prothrombinase complex. Methods Enzymol. 222, 260–280 (1993).

    Article  CAS  Google Scholar 

  9. Mann,K. G., Nesheim,M. E., Church,W. R., Haley,P. & Krishnaswamy,S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76, 1–16 (1990).

    CAS  PubMed  Google Scholar 

  10. Saenko,E. L. & Scandella,D. A mechanism for inhibition of factor VIII binding to phospholipid by von Willebrand factor. J. Biol. Chem. 270, 13826–13833 (1995).

    Article  CAS  Google Scholar 

  11. Takeshima,K. & Fujikawa,K. The phospholipid binding property of the C2 domain of human factor VIII. J. Biol. Chem. (submitted).

  12. Pellequer,J.-L., Gale,A. J., Griffin,J. H. & Getzoff,E. D. Homology models of the C domains of blood coagulation factors V and VIII: a proposed membrane binding mode for FV and FVIII C2 domains. Blood Cells Mol. Dis. 24, 448–461 (1998).

    Article  CAS  Google Scholar 

  13. Baumgartner,S., Hofmann,K., Chiquet-Ehrismann,R. & Bucher,P. The discoidin domain family revisited: new members from prokaryotes and a homology-based fold prediction. Protein Sci. 7, 1626–1631 (1998).

    Article  CAS  Google Scholar 

  14. Veeraraghavan,S., Baleja,J. D. & Gilbert,G. E. Structure and topography of the membrane-binding C2 domain of factor VIII in the presence of dodecylphosphocholine micelles. Biochem. J. 332, 549–555 (1998).

    Article  CAS  Google Scholar 

  15. Gilbert,G. E. & Baleja,J. D. Membrane-binding peptide from the C2 domain of factor VIII forms an amphipathic structure as determined by NMR spectroscopy. Biochemistry 34, 3022–3031 (1995).

    Article  CAS  Google Scholar 

  16. Haemostasis Research Group at the MRC Clinical Sciences Centre, Imperial College Medical School. Haemophilia A mutation database. http://europium.mrc.rpms.ac.uk/HAMSterS:

  17. Wolfenden,R., Andersson,L., Cullis,P. M. & Southgate,C. C. B. Affinities of amino acid side chains for solvent water. Biochemistry 20, 849–855 (1981).

    Article  CAS  Google Scholar 

  18. Hoyer,L. W. & Scandella,D. Factor VIII inhibitors: structure and function in autoantibody and hemophila A patients. Semin. Hematol. 31 (Suppl. 4), 1–5 (1994).

    Google Scholar 

  19. Healey,J. F. et al. Residues Glu2181–Val2243 contain a major determinant of the inhibitory epitope in the C2 domain of human factor VIII. Blood 92, 3701–3709 (1998).

    CAS  PubMed  Google Scholar 

  20. Jacquemin,M. G. et al. Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood 92, 496–506 (1998).

    CAS  PubMed  Google Scholar 

  21. Kuwabara,I. et al. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients. J. Immun. Methods 224, 89–99 (1999).

    Article  CAS  Google Scholar 

  22. Shima,M. et al. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine. Thromb. Haemost. 69, 240–246 (1993).

    Article  CAS  Google Scholar 

  23. Otwinowski,Z. & Minor,W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).

    Article  CAS  Google Scholar 

  24. Collaborative Computing Project 4. The CCP4 Suite: Programs for protein crystallography. Acta Cryst. D 50, 760–763 (1994).

    Article  Google Scholar 

  25. LaFortelle,E., Irwin,J. J. & Bricogne,G. in Crystallographic Computing Vol. 7 (eds Bourne, P. & Watenpaugh, K.) 100–130 (Oxford Science Publications, Oxford, 1997).

    Google Scholar 

  26. Nieh,Y.-P. & Zhang,K. Y. J. A 2D histogram matching method for protein phase refinement and extension. Acta Crystallogr. D (in the press).

  27. Jones,T. A., Zou,J.-Y., Cowan,S. W. & Kjeldgaard,M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110–119 (1991).

    Article  Google Scholar 

  28. Brunger,A. T. et al. Crystallography and NMR System. Acta Crystallogr. D 44, 905–921 (1998).

    Article  Google Scholar 

  29. Brunger,A. Assessment of phase accuracy by cross validation: the free R value. Methods and Applications. Acta Crystallogr. D 49, 24–36 (1993).

    Article  CAS  Google Scholar 

  30. Laskowski,R. J., Macarthur,M. W., Moss,D. S. & Thornton,J. M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26, 283–290 (1993).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank J. Bolduc, R. Strong, Y.-P. Nieh, K. Zhang, L. Steward, H. Kim and A. Thompson for advice and assistance. This work was funded by the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Barry L. Stoddard.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pratt, K., Shen, B., Takeshima, K. et al. Structure of the C2 domain of human factor VIII at 1.5 Å resolution. Nature 402, 439–442 (1999). https://doi.org/10.1038/46601

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/46601

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing